chrisvoncsefalvay/vaers-outcomes huggingface dataset:
First night tingling in feet.  Next light tingling in hands and feet.  Third day major tingling in hands, feet, one side of leg, and sides of face.
Patient took 1st dose of oral Typhoid 6/11/13 at 7pm and began to have abd. pain and "tightness" of abdomen 6/12/13 (Wed) accompanied by cramping and general "uncomfortableness". Took 2nd dose Thurs at 10:30 pm with "lots of water" and at 01:00 am had severe stomach pain, backache, and mom states she was "doubled over" by 4am. Was "hot with waves of pain". Went to MD that morning - blood work done but mom doesn't know which labs were drawn. She was also dx with UTI and was having her menstrual cycle. Her mom believes all 3 things most likely contributed to her symptoms. She was put on antibiotics, encouraged to eat something and eventually felt better that day and slept approx 15 hrs. Call on 6/18 to mom, and she said patient is fine now.
coughing; heaviness around chest; pink and itchy rash all over body; headache; pain at injection site; fever; confused consciousness; chills; This spontaneous case was reported by a consumer and describes the occurrence of ALTERED STATE OF CONSCIOUSNESS (confused consciousness) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (no medical history reported).   On 13-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 10-Apr-2021, the patient experienced ALTERED STATE OF CONSCIOUSNESS (confused consciousness) (seriousness criterion medically significant), CHILLS (chills), HEADACHE (headache), VACCINATION SITE PAIN (pain at injection site) and PYREXIA (fever). On 12-Apr-2021, the patient experienced COUGH (coughing), CHEST DISCOMFORT (heaviness around chest) and RASH (pink and itchy rash all over body). At the time of the report, ALTERED STATE OF CONSCIOUSNESS (confused consciousness), CHILLS (chills), COUGH (coughing), CHEST DISCOMFORT (heaviness around chest), RASH (pink and itchy rash all over body), HEADACHE (headache), VACCINATION SITE PAIN (pain at injection site) and PYREXIA (fever) outcome was unknown.            The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was not applicable. The treatment included paracetamol.  Company Comment: Based on the current available information and the temporal association between the product use and the start date of the events a causal relationship cannot be excluded.   This case was linked to MOD-2021-073931 (Patient Link).; Sender's Comments: Based on the current available information and the temporal association between the product use and the start date of the events a causal relationship cannot be excluded.
Client received varicella vaccine on 3/19/08.  Client developed chickenpox on 6/7/08, ran temp of 100.7, had 20 spots on legs and mouth.  Sought medical treatment/diagnosed by Dr. on 6/9/08
Incorrect dilute used and incorrect volume of dilute.  0.7 ml sterile water used to dilute.
She got her vaccine, she felt very weak, woozy, tired, lethargic.  Her blood pressure went up to 196/116 several days later.  She was sick for 5 weeks.  Her arm was a little achy, which was normal to her as she gets allergy shots which she has the same reaction to.  She called her doctor who was out on leave and they told her to go to UC.  She went to UC twice and the ER twice due to her BP and her weakness and dizziness.  She was not able to drive due to these symptoms.  They did increase her BP medication and he said that if it did not help then go to the ER.  She went to the ER and was still feeling very weak, and they told her that it was from the vaccine as they have seen other people with the same reactions, and it can last up to 6 weeks.  She said nobody knew what happened, she had CT scan of the head, EKG, blood work, chest x-ray and other tests.  She went to the cardiologist who believed that she had the COVID virus, and he ordered an echocardiogram that was normal.  She also had a LEXI-scan that was normal as well.     The symptoms finally went away and is back to normal now and said that it was exactly 5 weeks later that she finally felt better and was not dizzy or woozy any longer.  She felt as though she was going to die as she was so weak.    She feels that it needs to be explained further that it is not FDA approved and that the elderly do not understand what EUA means.
ER ROOM........... DIAHARREA    AM      600PM TO 300 AM VOMITING SAME TIME  HEADACHE   ER ROOM 1100 AM
Moderna COVID-19 Vaccine EUA.   Pain and tenderness at the injection site, which started out rather mild, but increased throughout the day. By around 5:30/6 PM I started experiencing fatigue, headache, muscle pain, chills and fever. I've been taking Tylenol, as suggested, which has helped immensely. Symptoms are still ongoing. (it's only a day later)
Pt previously received Johnson and Johnson vaccine on 4/2021. Received first dose Pfizer 7/6/2021. Received 2nd dose Pfizer today. Observed x 15 minute without reaction.
Information has been received from a physician concerning a male who in 1999, age 15 months, was vaccinated SC with a 0.5ml, first dose of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live. Subsequently, four days after immunization, the patient was hospitalized with a temperature of 105.0 degrees, and was diagnosed with Kawaski's disease. The child was treated with immunoglobulin and aspirin, and was discharged from the hospital 3 days later. In approximately March 2006, the child had titers for measles, mumps, and rubella drawn, and was found to have no immunity. The child was then given his second dose of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live, and developed a temperature of 101.0 after immunization. The child is now recovered. No other information was available at the time of the report. Kawaski's disease was considered to be disabling. No additional information is expected.
About 12 hours after the vaccine I started to have body aches and chills. I took Ibruprofen that evening and when I woke up the next morning I had a low grade fever of 99.5, I took Ibruprofen that morning and began sweating. I was sweaty/clammy all day, had a headache and tired. Around 4pm I took a 1.5 hour nap and felt better after that. The next morning I believe I had another low grade fever because I was really cold when I went to sleep, but woke up sweating. After that I have not had any symptoms.
pneumonia vaccine (2000 to present (2020)) annually; None side effects; Information received from a case in litigation (MARRS# 1902USA002463) referring to an adult female patient. From 2000 to present (2020), the patient was vaccinated with pneumococcal vaccine, polyvalent (23-valent)(PNEUMOVAX23) (reported as pneumonia vaccine) (dose, route of administration, anatomical location, lot#, expiration date were unknown) annually for prophylaxis (inappropriate schedule of product administration). The patient did not experience side effects.; Sender's Comments:  US-009507513-1902USA002463:
Presented to office with rash all over body. Ill and restless, mild fever. Dx with Varicella.
headache,myalgia,fever,nausea,fatigue x 3 days and on and off since
Patient developed 101F temp after DTaP and temp kept going up to > 105; responded to Tylenol, but fight temp and crying for 3 days. Now temp 101 with Tylenol; no trying now. No other symptoms occurred throughout. Mother phone to report and plans to see MD and get advice regarding future vaccine.
I got a headache within 15 minutes, which progressed. I was able to drive home, but by the time I got there is was very distracting. The next day I had a fever and muscle soreness. After about 33 hours, I felt recovered and had no further issues other than soreness in my arms.
Had jaw pain and swelling beginning 1/17/21, went to PCP 1/18/21 and she noted bulging ear drum but no real redness and said it could be an ear infection. (Did not have ear pain). Prescribed cefdinir and hydrocodone. Pain and swelling to the jaw worsened and then on 1/21/21 had spread to the neck and chin. PCP suggested I report to the ER where he did a CT scan and lab work. Lab work was wnl scan showed swelling to the lymph nodes. Diagnosed with lymphadenitis. Given a single does of steroids and told to continue the antibiotics to test any infection I might have.
IBS flare up; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient. Other Case identifier(s): US-PFIZER INC-2021766601 (Pfizer).  A 63 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 03May2021 (Lot number: EW0168) at the age of 63 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "IBS" (unspecified if ongoing), notes: Verbatim: IBS, Diagnosed over 20 years ago; "Gastrooesophageal reflux disease" (unspecified if ongoing), notes: Verbatim: Acid reflux (esophageal), Diagnosed over 20 years ago; "Headache" (unspecified if ongoing). Concomitant medication(s) included: LINZESS; FOLIC ACID; VIT D; VITAMIN B COMPLEX. Past drug history included: Aleve for Headache, reaction(s): "acid reflux worse", notes: takes Aleve for headaches, The Aleve makes the acid reflux worse so the caller usually only takes a half.  The following information was reported: CONDITION AGGRAVATED (non-serious) with onset 07May2021, outcome "not recovered", described as "IBS flare up".  Additional Information;The caller stated that IBS and has been pretty good about controlling his flare ups. The patient stated he had IBS flare ups 3-4 days after the first dose of the vaccine. The second vaccine was 3 weeks ago and the caller is getting another IBS flare up. The caller has not had any changes to his diet or stress levels.Caller stated he was feeling fine up until he took the vaccine and had more flare ups. Caller stated it could be coincidental or it could be something in the vaccine that triggered it.Reporter seriousness for IBS flare up was unspecified  No follow-up attempts are possible. No further information is expected.
This spontaneous case was reported by an emergency medical technician and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient received vaccine past its 30 days expiry date) and PRODUCT STORAGE ERROR (Vaccine went into 2-8 C thaw state on or about 24-Dec-2021 and administered on 18-Feb-2022) in a 46-year-old male patient who received mRNA-1273 (Spikevax) (batch no. 066H21A) for COVID-19 vaccination. No Medical History information was reported. On 18-Feb-2022 at 12:39 PM, the patient received second dose of mRNA-1273 (Spikevax) (unknown route) .5 milliliter. On 18-Feb-2022 at 12:39 PM, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient received vaccine past its 30 days expiry date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine went into 2-8 C thaw state on or about 24-Dec-2021 and administered on 18-Feb-2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient received vaccine past its 30 days expiry date) and PRODUCT STORAGE ERROR (Vaccine went into 2-8 C thaw state on or about 24-Dec-2021 and administered on 18-Feb-2022) outcome was unknown. For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments. The patient ethnicity was reported as white. Concomitant medication was not reported. Treatment medication was not reported. Patient received vaccine past its 30 day expiry date. Vaccine went into 2 to 8 degree Celsius thaw state on or about 24-Dec-2021. This vaccine was administered up until its manufacturing expiry date of 04-Apr-2022. Reporter no longer possess this lot number. On 18-Feb-2022 at 12:39:51 the patient was administered with second dose. This case was linked to MOD-2022-542869 (Patient Link).
change in eye sight: eyes very sensitive to light, muscles weak in my legs, feeling tired and weak, feeling sleepy, tightness in chest. Slept a lot for 3 days. 3rd night starting to feel better.
After vaccination, patient developed low-grade fever and diffuse bone pain.  Three days after vaccination, patient noted discomfort in ulnar distribution of left arm, as well as fullness in left antecubital region and left wrist.  Patient experiencing discomfort with lifting arm up and down.
Information has been received from a physician concerning a 12 month old female who, in February 2008, was vaccinated with MMR II. Concomitant therapy included VARIVAX, hepatitis A vaccine (inactive) (manufacturer unknown) and PREVNAR. Eleven days post vaccination, in approximately February 2008, the patient experienced measles described as a "system measles like rash." The patient was seen by the physician. The patient also experienced fever but on follow up visit the fever had disappeared. Subsequently, the patient recovered from measles with systemic measles like rash. This is one of two reports from the same source.  Additional information has been requested.
Information has been received from a legal firm regarding a case in litigation concerning a 15 month old male who was vaccinated with a first, second and third dose of hepatitis B vaccine recombinant on 9/13/95, 0.25CC, IM in the left thigh (lot 613797/0338B), on 11/16/95, 0.25mcg (0.25cc) IM in the right thigh (lot 613170/1013B) and 4/19/96, 25mcg (0.25cc) IM in the right thigh (lot 614910/1196B). Concomitant therapy included a first, second and third dose of Tetramune vaccine on 11/16/95, 0.5ml IM in the left thigh (lot 428039), on 4/19/96, 0.5ml IM in the left thigh (lot 428039), on 1/8/99 IM in the left thigh, a first dose of varicella virus vaccine live (Varivax) (lot 617693/0771D) SC in the left upper arm on 1/8/99, a first dose of MMR II (lot 616250/215D) SC in the right upper arm and a first and second dose of oral poliovirus vaccine (Orimune), 0.5ml, on 11/16/95 and 4/19/96. It is alleged that before completing the schedule of injections, the pt developed normally and demonstrated social, language, cognitive, behavioral and physical skills appropriate for his age. It is further alleged that beginning in approximately January 1997 (date not specified), the pt began to display symptoms of neurological damage consistent with mercury poisoning, including losing his language skills, engaging in repetitive and sterotypical behaviors, suffering from diminished cognitive ability and becoming socially withdrawn. The pt has since been diagnosed as suffering from mercury poisoning and disintegrative ("late onset," "degenerative," "regressive") autism, neurological injuries and mercury poisoning. It is also alleged that these injuries are permanent. Upon internal review, disintegrative ("late onset," "degenerative," "regressive") autism, neurological injuries and mercury poisoning were considered to be other medical events. No further info is available.  A 15-day follow up report received 6/23/2003 adds no new info.
A 4 year old male experienced muscle pain, fever of 103F, headache and nausea and vomiting after being treated with RabAvert. The pt received RabAvert post-exposure rabies prophylaxis. He received his 3rd dose (date unknown) and experienced the adverse events. Concurrent medications were unknown. Follow-up information has been requested.
COVID-19 (Booster) - both vaccines and booster were Pfizer booster on 10-29-21... symptoms were severe left arm soreness, extreme fatigue, extreme back pain - upper/middle/lower  still have left arm muscle soreness, moderate fatigue, back pain (right side only, middle/lower)
Around 2-3 hours after vaccines were given, pt developed sudden onset of leg pain and headache while sitting down.  The pt was given ibuprofen.  The pain progressed and she developed arm pain.  She had difficulty walking secondary to the pain and a feeling of numbness in her legs. ("walked like a duck" per mom).  She had no fever, no rash, no difficulty breathing.  She was evaluated in the ER.  After another 2 hours, pain was slightly improved where she could walk with less pain.  Evaluated again ~24hours after vaccine in my office.  Still c/o of pain, slight decreased strength in lower extremities, normal gait, no arm pain, no headache.
Atrial fibrillation; Muscle aches; Headache; This serious case was reported by a consumer via call center representative and described the occurrence of atrial fibrillation in a 69-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix with an associated reaction of pain in extremity (received 1st dose on an unknown date, refer case US2023AMR092037).   On 27-JUN-2023, the patient received the 2nd dose of Shingrix (left arm). In JUN-2023, an unknown time after receiving Shingrix, the patient experienced muscle pain (Verbatim: Muscle aches) and headache (Verbatim: Headache). On 27-JUN-2023, the patient experienced atrial fibrillation (Verbatim: Atrial fibrillation) (serious criteria GSK medically significant). The outcome of the atrial fibrillation was not resolved and the outcome of the muscle pain and headache were unknown.   It was unknown if the reporter considered the atrial fibrillation, muscle pain and headache to be related to Shingrix.     It was unknown if the company considered the atrial fibrillation, muscle pain and headache to be related to Shingrix.   Linked case(s) involving the same patient:  US2023AMR092037   Additional Information: GSK Receipt date: 29-JUN-2023 The patient self-reported this case. The patient had headache and muscle aches but also stated he experienced atrial fibrillation that began one hour after the administration of Shingrix. The reporter stated that his diagnosis was confirmed as atrial fibrillation on 29th June 2023. The reporter stated that his cardiologist would perform a cardioversion on him soon.  The reporter consented to follow up. This case was linked with case US2023AMR092037 with Same patient.; Sender's Comments:  US-GSK-US2023AMR092037:Same patient
No additional AE reported; a dose of GARDASIL 9 that experienced a temperature excursion was administered to a patient; This spontaneous report was received from a medical assistant and refers to a patient of unknown age and gender. No information regarding the patient's pertinent medical history, drug reactions or allergies and concomitant therapies was provided.  On 04-AUG-2021, the patient was vaccinated with an improperly stored dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) injection in prefilled syringe, lot # T029522, expiration date reported as 13-MAR-2022, but upon internal verification it was established as 13-MAR-2023, 0.5 milliliter (injection site and route of administration were not provided) for prophylaxis.  The administered dose experienced a temperature excursion of -4.8 degrees Celsius for 20 minutes. No previous temperature excursion had occurred. No additional adverse event was reported.  This is one of several reports received from the same reporter. combinationproductreport: Yes; brandname: GARDASIL 9 SYRINGE (DEVICE); commondevicename: HPV rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast); productcode: FMF; devicetype: SYRINGE, PISTON (FMF); manufacturername: Merck Sharp & Dohme Corp.; devicelotnumber: T029522; expirationdate: 13-MAR-2023; deviceage and unit: 0 ; malfunction: Unknown; deviceusage: Initial; reasonfornoneval: 81 Other; labeledsingleusedevice: No; mdcpreportability: No; mdcpreprationale: Case information does not meet criteria for reportability; Sender's Comments:  US-009507513-2108USA003020: US-009507513-2108USA003314: US-009507513-2108USA003135: US-009507513-2108USA003288: US-009507513-2108USA003100: US-009507513-2108USA003123:
Information has been received from a registered nurse concerning a patient who received the RECOMBIVAX HB series on schedule in 2008 and had a slightly positive hepatitis B titer. The patient received vaccinations from lot #s 660951/0398X, 662114/0866X and 660951/0399X (not corresponding doses specified). The nurse also stated that the RECOMBIVAX HB was properly stored while in her facility. At the time of the report the patient had not recovered. It was unspecified if the patient sought medical attention. This is one of several reports received from the same source. Additional information has been requested.
I couldn't walk; Stomach ache; breath was short; sore arm; one very tired; a big bump on the arm; chills; This is a spontaneous report from a contactable consumer(patient). A 58-years-old patient of unspecified gender had received bnt162b2 (PFIZER COVID-19 VACCINE, Solution for injection, Batch/Lot number EW0171, Expiration date: 30Nov2021), dose 2 via an unspecified route of administration on an unspecified date as DOSE 2, SINGLE for covid-19 immunization. The patient medical history and concomitant medications were not reported. It was reported that patient was healthy before taking vaccination. The patient previously took bnt162b2 (PFIZER COVID-19 VACCINE, Solution for injection, Batch/Lot number unknown, Expiration date: unknown ), dose 1 via an unspecified route of administration on an unknown date as DOSE 1, SINGLE for covid-19 immunization and patient had sore arm. On an unknown date in 2021, the second vaccine, one very tired day with the sore arm, a big bump on the arm but that was the side effects that was it was one sore arm and one tired day. When paraphrased the concern, patient stated, "Right, the chills, a small fever, a stomach ache, very tired, a very sore arm. patient even had one day when patient thought like my breath was short, patient was so tired, patient couldn't walk. patient felt for three days. The clinical outcome of the events were unknown. No follow-up attempts are needed. No further information is expected.
Pt states she was a little dizzy before she went to bed 10-14-10. When she woke up at 6 AM on 10-15-10 she was nauseated and threw up at 7:30A. States she ran fever the rest of the day (she never checked her temp. but could feel she was running fever). The next day she woke up and felt much better. Her arm was sore for 3-4 days.
pt recvd vax 30OCT95 5PM & about 8PM turned cyanotic & ahd a 10min petite mal sz;stop breathing for a min until shook her;
Started experiencing blackouts, whole body weakness, shortness of breath, muscle aches after HPV vaccine. Got so weak couldn't open door.  Went back to doctor repeatedly who said it couldn't be vaccine.  However, when tried to do gymnastics, muscles so weak, clavicle started popping out of sternum (which they said was impossible but did a few times.)  Had to quit gymnastics the following month after the vaccine because no longer could do hand stand or bars etc. 2 years later better but she struggles to do 2 push ups and shakes a lot doing that. She can't do gymnastics which was her life long dream.  Even though we went to doctor and said this is what happened they always tried to attribute to something else that they could never discover what that something else was.  They didn't even tell me there was this vaccine reporting system!
Sever headache that lasted for a week and a rash all over that has itched and burned  which I still have